Skip to main content

CU Index®* Panel

Test Code: 403005P
Expand All Collapse All
Clinical and Procedure
Clinical Utility

see individual test information

Procedure

see individual test information

Turnaround Time

2-5 business days from receipt of specimen

Specimen Information
Specimen Type Test Code CPT Code NY Approved Volume Assay Range Special Instructions
serum 403005P 86376 (x1), 86800 (x1), 84443 (x1), 86352 (x1) Yes

1 mL (min. 150 uL)

See Individual Tests

  • 3 mL should be collected and allowed to clot prior to centrifugation.
  • Patients taking calcineurin inhibitors should stop their medication for 72 hours prior to draw. Patients taking Prednisone should be off their medication for 2 week prior to draw
  • If specimen is to be held for more than a week, it should be stored frozen until shipped.
Disclaimer

Specimens are approved for testing in New York only when indicated in the Specimen Information field above.

The CPT codes provided are based on Viracor Eurofins' interpretation of the American Medical Association's Current Procedural Terminology (CPT) codes and are provided for general informational purposes only. CPT coding is the sole responsibility of the billing party. Questions regarding coding should be addressed to your local Medicare carrier. Viracor Eurofins assumes no responsibility for billing errors due to reliance on the CPT codes illustrated in this material.

*Patent No.: US 7, 824, 877. Use of intellectual property owned by Viracor Eurofins' to recreate, replicate or attempt in any way to determine the structure or composition of a patented or proprietary assay ("Product") is strictly prohibited and may be considered patent infringement. Further, modifying the Product, creating derivatives thereof or improvements thereon, or use of Viracor Eurofins' Products and test results to evaluate, validate or certify a competing assay, may also be considered patent infringement. Please contact Viracor Eurofins' at 800-305-5198 with any questions regarding its patents, or visit www.uspto.gov for general information on patent and IP law policy. 

Back to top